drugset / Trial / NCT02462720

COMFORT: A Multicenter, Open-label, Randomized, Crossover Study

NCT02462720

Phase 4 Completed 35 enrolled Boston Scientific Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate pain the patient experienced following treatment of varicose veins with Varithena® compared to radiofrequency ablation.

Timeline

Start
2015-05
Primary completion
2015-12
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Polidocanol Other / unclassified

Indications